These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

422 related items for PubMed ID: 12649192

  • 1. Enhanced cisplatin cytotoxicity by disturbing the nucleotide excision repair pathway in ovarian cancer cell lines.
    Selvakumaran M, Pisarcik DA, Bao R, Yeung AT, Hamilton TC.
    Cancer Res; 2003 Mar 15; 63(6):1311-6. PubMed ID: 12649192
    [Abstract] [Full Text] [Related]

  • 2. [Relationship between nucleotide excision repair gene ERCC1 and resistance to cisplatin in ovarian cancer].
    Liu GY, Qu QX, Mi RR, Qi J.
    Zhonghua Zhong Liu Za Zhi; 2008 Mar 15; 30(3):184-7. PubMed ID: 18756932
    [Abstract] [Full Text] [Related]

  • 3. Lactacystin enhances cisplatin sensitivity in resistant human ovarian cancer cell lines via inhibition of DNA repair and ERCC-1 expression.
    Li QQ, Yunmbam MK, Zhong X, Yu JJ, Mimnaugh EG, Neckers L, Reed E.
    Cell Mol Biol (Noisy-le-grand); 2001 Mar 15; 47 Online Pub():OL61-72. PubMed ID: 11936875
    [Abstract] [Full Text] [Related]

  • 4. [Enhanced cisplatin cytotoxicity by RNA interfering the excision repair cross-complementing 1 gene in ovarian cancer cell lines].
    Liu GY, Qu QX, Mi RR, Qi J.
    Zhonghua Fu Chan Ke Za Zhi; 2006 May 15; 41(5):339-42. PubMed ID: 16762192
    [Abstract] [Full Text] [Related]

  • 5. [Enhancement effect of nucleotide excision repair gene xeroderma pigmentosun group a antisense RNA on sensitivity of human lung adenocarcinoma cell line A549 to cisplatin].
    Fan W, Zhang HL, Wu XM.
    Ai Zheng; 2005 Apr 15; 24(4):403-7. PubMed ID: 15820060
    [Abstract] [Full Text] [Related]

  • 6. The impacts of ERCC1 gene exon VIII alternative splicing on cisplatin-resistance in ovarian cancer cells.
    Sun Y, Li T, Ma K, Tian Z, Zhu Y, Chen F, Hu G.
    Cancer Invest; 2009 Nov 15; 27(9):891-7. PubMed ID: 19832035
    [Abstract] [Full Text] [Related]

  • 7. Alterations in the expression of the apurinic/apyrimidinic endonuclease-1/redox factor-1 (APE1/Ref-1) in human ovarian cancer and indentification of the therapeutic potential of APE1/Ref-1 inhibitor.
    Zhang Y, Wang J, Xiang D, Wang D, Xin X.
    Int J Oncol; 2009 Nov 15; 35(5):1069-79. PubMed ID: 19787261
    [Abstract] [Full Text] [Related]

  • 8. [Study of bcl-2 antisense oligodeoxynucleotides on reversal of cisplatin resistance in ovarian cancer cell line A2780/DDP].
    Li M, Yu LL, Cai LQ, Wang HB, Wang ZH, Wang ZH.
    Zhonghua Fu Chan Ke Za Zhi; 2006 Feb 15; 41(2):121-5. PubMed ID: 16640863
    [Abstract] [Full Text] [Related]

  • 9. Regulation of DNA repair gene expression in human cancer cell lines.
    McGurk CJ, Cummings M, Köberle B, Hartley JA, Oliver RT, Masters JR.
    J Cell Biochem; 2006 Apr 01; 97(5):1121-36. PubMed ID: 16315315
    [Abstract] [Full Text] [Related]

  • 10. A truncated human xeroderma pigmentosum complementation group A protein expressed from an adenovirus sensitizes human tumor cells to ultraviolet light and cisplatin.
    Rosenberg E, Taher MM, Kuemmerle NB, Farnsworth J, Valerie K.
    Cancer Res; 2001 Jan 15; 61(2):764-70. PubMed ID: 11212280
    [Abstract] [Full Text] [Related]

  • 11. Regulation of HtrA2/Omi by X-linked inhibitor of apoptosis protein in chemoresistance in human ovarian cancer cells.
    Yang X, Xing H, Gao Q, Chen G, Lu Y, Wang S, Ma D.
    Gynecol Oncol; 2005 May 15; 97(2):413-21. PubMed ID: 15863139
    [Abstract] [Full Text] [Related]

  • 12. Association between the level of ERCC-1 expression and the repair of cisplatin-induced DNA damage in human ovarian cancer cells.
    Li Q, Yu JJ, Mu C, Yunmbam MK, Slavsky D, Cross CL, Bostick-Bruton F, Reed E.
    Anticancer Res; 2000 May 15; 20(2A):645-52. PubMed ID: 10810335
    [Abstract] [Full Text] [Related]

  • 13. [RNA interference silencing excision repair cross-complementing 1 gene and affecting cisplatin sensitivity on lung cancer cell lines].
    Shang XB, Yu ZT, Tang P, Zhang XZ.
    Zhonghua Yi Xue Za Zhi; 2008 Oct 28; 88(39):2799-802. PubMed ID: 19080461
    [Abstract] [Full Text] [Related]

  • 14. XPA versus ERCC1 as chemosensitising agents to cisplatin and mitomycin C in prostate cancer cells: role of ERCC1 in homologous recombination repair.
    Cummings M, Higginbottom K, McGurk CJ, Wong OG, Köberle B, Oliver RT, Masters JR.
    Biochem Pharmacol; 2006 Jul 14; 72(2):166-75. PubMed ID: 16756962
    [Abstract] [Full Text] [Related]

  • 15. Sensitization to the cytotoxicity of cisplatin by transfection with nucleotide excision repair gene xeroderma pigmentosun group A antisense RNA in human lung adenocarcinoma cells.
    Wu X, Fan W, Xu S, Zhou Y.
    Clin Cancer Res; 2003 Dec 01; 9(16 Pt 1):5874-9. PubMed ID: 14676109
    [Abstract] [Full Text] [Related]

  • 16. Messenger RNA levels of XPAC and ERCC1 in ovarian cancer tissue correlate with response to platinum-based chemotherapy.
    Dabholkar M, Vionnet J, Bostick-Bruton F, Yu JJ, Reed E.
    J Clin Invest; 1994 Aug 01; 94(2):703-8. PubMed ID: 8040325
    [Abstract] [Full Text] [Related]

  • 17. Gene-specific repair of Pt/DNA lesions and induction of apoptosis by the oral platinum drug JM216 in three human ovarian carcinoma cell lines sensitive and resistant to cisplatin.
    O'Neill CF, Koberle B, Masters JR, Kelland LR.
    Br J Cancer; 1999 Dec 01; 81(8):1294-303. PubMed ID: 10604725
    [Abstract] [Full Text] [Related]

  • 18. Acquired cisplatin resistance in human ovarian cancer cells is associated with enhanced repair of cisplatin-DNA lesions and reduced drug accumulation.
    Parker RJ, Eastman A, Bostick-Bruton F, Reed E.
    J Clin Invest; 1991 Mar 01; 87(3):772-7. PubMed ID: 1999494
    [Abstract] [Full Text] [Related]

  • 19. Effect of lung resistance-related protein on the resistance to cisplatin in human ovarian cancer cell lines.
    Wang W, Ke S, Chen G, Gao Q, Wu S, Wang S, Zhou J, Yang X, Lu Y, Ma D.
    Oncol Rep; 2004 Dec 01; 12(6):1365-70. PubMed ID: 15547764
    [Abstract] [Full Text] [Related]

  • 20. Epigallocatechin-3-gallate delivers hydrogen peroxide to induce death of ovarian cancer cells and enhances their cisplatin susceptibility.
    Chan MM, Soprano KJ, Weinstein K, Fong D.
    J Cell Physiol; 2006 May 01; 207(2):389-96. PubMed ID: 16402374
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.